Genovate Biotechnology Co., Ltd. (Taiwan, China)

Genovate Biotechnology Co.,Ltd.(Genovate Biotechnologies Co.,Ltd.) was established in March 1993.In April 1993 it put into the research and development of anti-cancer agents. In March 1997 it distributed western medicine of Bristol-Myers Squibb. In July 1998 it went public. In November 2002 it got Roche's Ribavirin global OEM.In January 2007 the company declared the suspension of the merger with Hong Ru Yang. The main source of revenue comes from the pharmaceutical manufacturing, foundry and technology services (including clinical trials). In addition to the R & D in the fields of the original sub-chronic, age-related diseases, cancer, cardiovascular, metabolic, mental and functional psychosis, the company cooperated with the domestic and international research institutions in the development projects of the new medicine like the me-too drug.